Cargando…

Breaking dogma for future therapy using stem cell - Where we have reached?

Detalles Bibliográficos
Autor principal:	Verma, Rama S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859121/ https://www.ncbi.nlm.nih.gov/pubmed/27121510 http://dx.doi.org/10.4103/0971-5916.180195

Ejemplares similares

Challenges to the Common Dogma
por: Yu, Jun
Publicado: (2012)

Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Decoding methods for neural prostheses: where have we reached?
por: Li, Zheng
Publicado: (2014)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

The tube, the pancreatoduodenectomy—and the dogma
por: Lassen, Kristoffer
Publicado: (2021)

Stem Cell Therapy in Bladder Dysfunction: Where Are We? And Where Do We Have to Go?
por: Kim, Jae Heon, et al.
Publicado: (2013)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Cannabinoid receptor type-1: breaking the dogmas
por: Busquets Garcia, Arnau, et al.
Publicado: (2016)

The Transcription Factor Function of Parkin: Breaking the Dogma
por: Alves da Costa, Cristine, et al.
Publicado: (2019)

Immunotherapy of brain metastases: breaking a “dogma”
por: Di Giacomo, Anna Maria, et al.
Publicado: (2019)

Advancing global change biology through experimental manipulations: Where have we been and where might we go?
por: Hanson, Paul J., et al.
Publicado: (2019)

National Mental Health Policy, India (2014): Where Have We Reached?
por: Gupta, Snehil, et al.
Publicado: (2021)

Incidence of Primary Hyperparathyroidism in the Current Era: Have We Finally Reached a Steady State?
por: Wermers, Robert A
Publicado: (2023)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Biology Past and Biology Future: Where have we been and where are we going
Publicado: (2013)

Commentary: Temerity trumps dogma: The dangerous road of innovation
por: Cerfolio, Robert J.
Publicado: (2021)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Recently published papers: Changing bandwagons, innovations and questioning dogma
por: Ball, Jonathan
Publicado: (2009)

Anti-cytokine therapy in fibrosing alveolitis: where are we now?
por: Millar, Ann
Publicado: (2000)

Implementation of Outpatient Total Joint Arthroplasty in Canada: Where We are and Where We Need to Go
por: Zomar, Bryn O, et al.
Publicado: (2020)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Introduction to sessions on 'Endocrine therapy: where have we come from, where are we at and where are we going to?'
por: Ingle, James N
Publicado: (2008)

Australia's public health response to COVID‐19: what have we done, and where to from here?
por: Johnston, Ingrid
Publicado: (2020)

One Size Fits All: Does the Dogma Stand in Radiation Oncology?
por: Azria, David, et al.
Publicado: (2016)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Commentary: Dogma to diachronicity: Evolving to lesion-specific repair of Barlow valves
por: Spear, Charlotte, et al.
Publicado: (2021)

Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?
por: Mu, Jun, et al.
Publicado: (2011)

Where we are with point-of-care testing
por: Johannessen, A
Publicado: (2015)

Electronic cigarettes – where are we headed?
por: Loughead, Andrew
Publicado: (2015)

Etomidate for intubation of patients who have sepsis or septic shock - where do we go from here?
por: Griesdale, Donald EG
Publicado: (2012)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Dermatology education in skin of colour: where we are and where do we go?
por: Onasanya, Joshua, et al.
Publicado: (2021)

Quo vadis: Where have the β-cells gone?
por: Yagihashi, Soroku, et al.
Publicado: (2015)

Breaking Barriers to Reach Farther: A Call for Urgent Action on Tele-ICU Services
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2020)

Challenging management dogma where evidence is non-existent, weak or outdated
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irrfs999h7eis2ha9tv51clsca